# Buspirone in the Treatment of 2-6 Year Old Children With Autistic Disorder

> **NCT00873509** · PHASE2,PHASE3 · COMPLETED · sponsor: **Chugani, Diane C.** · enrollment: 166 (actual)

## Conditions studied

- Autistic Disorder

## Interventions

- **DRUG:** Buspirone
- **DRUG:** Buspirone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00873509
- **Lead sponsor:** Chugani, Diane C.
- **Sponsor class:** INDIV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2016-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00873509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00873509, "Buspirone in the Treatment of 2-6 Year Old Children With Autistic Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00873509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*